Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cyclopamine interferes with genetic cancer signaling pathways

Sep. 27, 2000

Corixa and Purdue establish agreement for therapeutic antibodies for cancer

Sep. 26, 2000

FDA denies approval of Foscan

Sep. 26, 2000

Aptosyn NDA for FAP indication not approvable at this time

Sep. 26, 2000

Protein farnesyltransferase inhibitors and their use in cancer treatment described by Pfizer

Sep. 26, 2000

Roche discloses novel MMP inhibitors particularly useful in the control of cancer

Sep. 26, 2000

Synthesis and use of quinazoline-based VEGF receptor tyrosine kinase inhibitors

Sep. 26, 2000

Coulter acquires rights to anticancer compounds

Sep. 26, 2000

Exisulind/docetaxel combination prolongs survival in animal model of lung cancer

Sep. 25, 2000

New series of MMP inhibitors for inhibiting tumor growth and metastasis

Sep. 25, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...